Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > ict > Winter 2020

PUBLICATIONS

International Clinical Trials

Winter 2020

Text

PDF

Features

Keeping Trials Connected

Stephen Byrne at KORE

Adopting a more connected clinical trial system can overcome the problems faced by constantly evolving technology and network sunsetting.

Paediatric Trials

We Can Do Better: Key Considerations for Paediatric Trial Success

Mark Sorrentino at PRA Health Sciences

Enrolment and recruitment challenges in paediatric trials may be mitigated by aspects of trial design that are within our control.

RACE for Children Act: Product Development Considerations

Lynne Georgopoulos at Synteract

August 2020 will bring new regulations on cancer drugs for paediatric patients, raising questions on the requirements of drug developers.

Removing Barriers for Paediatric Patients in Clinical Trials

Evelyn Kamau at the MRN

The disparity in clinical trials conducted on adult patients vs children brings important discussions on quality-based care for paediatric patients.

Spotlight

Think of the Children: Clinical Trial Considerations at Home

Illingworth Research Group presents how it tackles the challenges of paediatric patient retention and consent in clinical trials.

Optimising Trial Design Across the Ages

Michael Oldham, MD, Michelle Petersen, Katharine Shore, and Christina Vonderhaar at Medpace

Regulatory interest in paediatric trials continues to mount, and careful planning across multiple functional areas in trial design is becoming even more vital.

Clinical Trial Supply

IMP Integrity

Vincent Santa Maria and Tony Heeley at Parexel International

Robust planning and optimisation are essential to future-proof the supply chain for investigational medicinal products.

The Drivers of Success in Ancillary Supply Chain Management

Dr Joanne Santomauro at Ancillare

While pharma companies increasingly focus on outsourcing efforts, effective ancillary supply chain management is often neglected.

Spotlight

The Difference a Step Makes

Signant Health explains the value of a purpose-built supply chain management solution.

Comparator Sourcing in Clinical Studies (Part One of Two)

Toby Watkins at CTSS

The first of this two-part article gives a broad overview of the challenges inherent in comparator sourcing, as well as key players in comparator supply.

The Rise of Direct-to-Patient

Brian Swites at Clinigen Group

With a shift in focus in the healthcare industry towards patient centricity, a direct-to-patient supply chain continues to grow in popularity.

Comparator Sourcing in China: Three Key Trends for a New Decade

Viktor Sandstedt at Inceptua

During the 2010s, there were many barriers to trial opportunities in China, but these challenges may be surpassable.

Data Protection

Harmonising Requirements in the EU

Magdalena Lewandowska at DIA

There are important distinctions to make around the interplay of EU CTR and GDPR across the product lifecycle.

Security, Compliance, and Control

Georgina Stockley at Boldon James

Five key steps can be identified to avoid accidental data loss or leakage, which is vital for maintaining effective data protection.

The Impact of GDPR for Health Organisations

Luis Ángel del Valle at SealPath

The 2018 EU GDPR was the first major push by health organisations in a growing effort to protect previously susceptible patient data.

Published quarterly in
February, May,
August, and November

News and Press Releases

Sustainability takes centre stage for Tower Cold Chain at LogiPharma

Temperature-controlled specialist Tower is returning to LogiPharma in 2023 to showcase how pharmaceutical manufacturers are using its passive containers to improve their logistics infrastructure, in today’s sustainably inclined world.
More info >>

All releases >>

White Papers

7 Common Myths about QP Training Debunked: A Guide for Senior Managers

RSSL

The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >>

All white papers >>